Skip to main content
OpenTrials

Clinical trial condition

B-cell Acute Lymphoblastic Leukemia

Explore clinical trials studying B-cell Acute Lymphoblastic Leukemia. Study availability and eligibility vary by location and protocol.

62 public trials 39 recruiting studies
Refine in advanced search Browse all conditions

B-cell Acute Lymphoblastic Leukemia trial results

Completed

Study of Efficacy and Safety of CTL019 in Pediatric ALL Patients

NCT02228096

Conditions
B-cell Acute Lymphoblastic Leukemia, Burkitt Lymphoma, DNA Virus Infections, +25 more
Locations
  • Childrens Hospital Los Angeles SC Los Angeles, California, United States
  • Stanford University Medical Center Palo Alto, California, United States
  • Children's Healthcare of Atlanta SC-2 Atlanta, Georgia, United States
  • University of Michigan Ann Arbor, Michigan, United States
View all 13 locations
View Trial Details
Completed

Confirmatory Phase II Study of Blinatumomab (MT103) in Patients With Minimal Residual Disease of B-precursor Acute Lymphoblastic Leukemia (ALL)

NCT01207388

Conditions
B-cell Acute Lymphoblastic Leukemia, Burkitt Lymphoma, DNA Virus Infections, +23 more
Locations
  • 1102 - LKH Graz Graz, Austria
  • 1107 - Krankenhaus der Elisabethinen Linz, Austria
  • 1106 Salzburg, Austria
  • 1101 - AKH Wien Vienna, Austria
View all 75 locations
View Trial Details
Active, Not Recruiting

Study of Efficacy and Safety of Tisagenlecleucel in HR B-ALL EOC MRD Positive Patients

NCT03876769

Conditions
B-cell Acute Lymphoblastic Leukemia, Burkitt Lymphoma, DNA Virus Infections, +19 more
Locations
  • Children s Hospital of Alabama Birmingham, Alabama, United States
  • Phoenix Childrens Hospital Phoenix, Arizona, United States
  • City of Hope National Medical Duarte, California, United States
  • Childrens Hospital Los Angeles Los Angeles, California, United States
View all 43 locations
View Trial Details
Active, Not Recruiting

NKX019, Intravenous Allogeneic Chimeric Antigen Receptor Natural Killer Cells (CAR NK), in Adults With B-cell Cancers

NCT05020678

Conditions
Aggressive Lymphoma, B-cell Acute Lymphoblastic Leukemia, Blood Protein Disorders, +43 more
Locations
  • Colorado Blood Cancer Institute Denver, Colorado, United States
  • The Cleveland Clinic Foundation Cleveland, Ohio, United States
  • Institute of Haematology, Royal Prince Alfred Hospital Camperdown, New South Wales, Australia
  • St. Vincent's Hospital Sydney, New South Wales, Australia
View Trial Details
Active, Not Recruiting

A Second Infusion (Early Reinfusion) of Tisagenlecleucel in Children and Young Adults With B-Cell Acute Lymphoblastic Leukemia(B-ALL)

NCT05460533

Conditions
B-cell Acute Lymphoblastic Leukemia, Burkitt Lymphoma, DNA Virus Infections, +19 more
Locations
  • Children's Hospital of Los Angeles (Data Collection Only) Los Angeles, California, United States
  • Stanford University (Data Collection Only) Stanford, California, United States
  • Children's Hospital Colorado (Data Collection Only) Aurora, Colorado, United States
  • Johns Hopkins University (Data Collection Only) Baltimore, Maryland, United States
View Trial Details
Active, Not Recruiting

Venetoclax Plus Inotuzumab for B-ALL

NCT05016947

Conditions
ALL, B-cell Acute Lymphoblastic Leukemia, B-cell Lymphoma, +17 more
Locations
  • Brigham and Women's Hospital Boston, Massachusetts, United States
  • Dana Farber Cancer Institute Boston, Massachusetts, United States
View Trial Details

Related conditions